Cochrane review challenges benefits of turmeric supplements for knee osteoarthritis

A new Cochrane review has found that turmeric supplements may provide little or no clinically important pain relief for people with knee osteoarthritis, challenging conclusions from earlier research that suggested a benefit.

Osteoarthritis is a complex joint disease and the most common type of arthritis. While treatments such as exercise and medication can help manage symptoms, there is currently no cure.

Turmeric, a common culinary spice, contains compounds known as curcuminoids, including curcumin, which have anti-inflammatory properties. Because inflammation contributes to osteoarthritis symptoms, turmeric supplements have attracted considerable interest as a potential treatment.

Doubt cast over benefits of turmeric for arthritis

An international group of researchers examined 9 studies including 1,245 people with knee osteoarthritis. The studies compared turmeric supplements with placebo, non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and diclofenac, and paracetamol.

The studies investigated a range of turmeric extracts and curcuminoid-based products. The products differed in their composition, curcuminoid content and dosage.

Participants were aged between 52 and 62 years on average, around two-thirds were women, and the studies were conducted in Australia, Belgium, India and Thailand. The trials were relatively short, lasting between four weeks and three months.

Overall, the current evidence does not demonstrate a clear clinical benefit. Compared to placebo and anti-inflammatory drugs, turmeric was not shown to be more effective. However, the available evidence remains uncertain due to limitations in the underlying studies.

Dr Ivan Shirinsky, lead author of the review and a practicing rheumatologist, says: "As a clinician and researcher, I am not surprised by these findings. Osteoarthritis is a complex and still incompletely understood disease. Despite intensive research, effective pharmacological treatment options remain limited, and many promising approaches have yielded limited or inconclusive evidence of clinical benefit. A better understanding of the mechanisms underlying osteoarthritis may help us develop more effective treatments in the future."

Why checking the trustworthiness of clinical trials matters

Previous systematic reviews generally suggested that turmeric may improve pain and physical function in people with osteoarthritis. However, some of these findings may have been influenced by studies whose trustworthiness had not been formally assessed.

The new Cochrane review incorporated formal assessments of trial trustworthiness, providing an additional safeguard when evaluating the available evidence. Notably, 10 trials raised concerns during trustworthiness screening and were placed in the awaiting classification category pending clarification from their authors. These trials were not included in the analyses because the concerns remained unresolved.

The authors note that earlier reviews often included a wider range of studies, including trials based only on radiographic diagnoses of osteoarthritis, non-oral turmeric preparations, or curcumin products combined with other active ingredients. Earlier reviews also did not apply the same trustworthiness screening procedures. Differences in study selection and methodology, including the assessment of trial trustworthiness, may help explain why the new Cochrane review reached more cautious conclusions than previous reviews.

"This review highlights the importance of assessing the trustworthiness of clinical trials," adds Dr Shirinsky. "Such assessments help identify studies that require further clarification before their findings can be used to inform conclusions about treatment effects."

Asked whether he would recommend turmeric supplements to patients with knee osteoarthritis, Dr Shirinsky says: "I would not routinely recommend turmeric supplements to my patients with knee osteoarthritis. However, if a patient asked me about them, I would explain what we know and what remains uncertain about their benefits and potential harms, and help them make an informed decision."

The authors used the Trustworthiness Screening Tool developed by the Cochrane Pregnancy and Childbirth group. Similar tools have since been developed, including INSPECT-SR, which is designed to help researchers identify problematic studies that may distort evidence syntheses.

Source:
Journal reference:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exercise therapy reduces knee osteoarthritis risk after ACL surgery